Deepseq
2 known investors
DeepSeq develops AI-designed biologics, using datasets of billions to trillions of real protein interactions to predict properties such as binding affinity, specificity, immunogenicity, pharmacokinetics, and manufacturability. The platform aims to accelerate the development of better drugs for patients.
AI & Machine LearningBiotechDeep Tech
Investors · 2
Competitors · 3
by search overlapDeepSee5 shared keywordsDeepSee.ai develops technology aimed at supporting knowledge workers and improving business operations. The page provides limited detail beyond a hiring notice.
Genomeweb5 shared keywordsGenomeWeb's Research Funding section publishes news coverage of research grants and government funding trends in genetics, genomics, and molecular diagnostics. It is an industry news publication serving researchers and organizations in the life sciences.
Deepchecks4 shared keywordsDeepchecks offers an enterprise LLM evaluation platform that unifies testing, observability, and monitoring for AI systems in production. It lets AI teams compare prompt/model/agent versions, set up auto-scoring pipelines, create LLM judges and datasets, and integrate LLM app testing into CI/CD.
Companies competing with Deepseq for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Deepseq do?
- DeepSeq develops AI-designed biologics, using datasets of billions to trillions of real protein interactions to predict properties such as binding affinity, specificity, immunogenicity, pharmacokinetics, and manufacturability. The platform aims to accelerate the development of better drugs for patients.
- Who are Deepseq's investors?
- Deepseq's investors include Illumina Ventures, ZAKA VC.